Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

<p>– On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Half of 2023 – WALTHAM, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/dyne-therapeutics-reports-second-quarter-2023-financial-results-and-business-highlights/">Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>